The available literature also suggests that USP39 promotes the progression of ovarian carcinoma cells via inhibition of the p53-p21 pathway and Wnt pathway with evidence of an impact of knockdown on the in vivo growth 105. The gene discussed is TP53; the disease is ovarian carcinoma.